PBM and Insurer Groups Testify Against Bill Limiting Midyear Formulary Changes
Oct 21, 2025
Opponents including the Pharmaceutical Care Management Association and Ohio Association of Health Plans told the Senate committee that Senate Bill 160, intended to limit nonmedical switching midyear, could raise costs for employers and plans and complicate formulary management.
The full story
Sean Stevenson, representing the Pharmaceutical Care Management Association (PCMA), testified in opposition to Senate Bill 160, which the bill sponsor says would prevent nonmedical switching of prescription drugs during a plan year. "The intent of Senate Bill 160 is to prevent non medical switching of prescription drugs during a planned year," Stevenson said, adding that prescription drug formularies sometimes change during the year due to new medications, generics, safety updates or price changes.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in →